At T-NanoBio Therapeutics, we are committed to developing a transformational peptide nanoparticle pipeline to target a broad range of cancer types. Our lead product is the Nano Immuno-Engager (“NIE”) for cancer immunotherapy in combination with checkpoint inhibitors.
